Margolius H S
Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston 29425-2251, USA.
Diabetes. 1996 Jan;45 Suppl 1:S14-9. doi: 10.2337/diab.45.1.s14.
Kallikrein-kininogen-kinin systems are now topics of widespread interest. The long-standing appreciation of their diverse pharmacological properties and biochemical characteristics is being supplemented by modern definitions of their cellular receptors' signal-transduction mechanisms and physiological and pathological roles. The assignment of important homeostatic responsibilities for kinins, including those in autocrine and paracrine signaling for skeletal and cardiac muscle energy metabolism, is now subject to definitive experimental evaluation via the availability of better kallikrein inhibitors, specific kinin receptor antagonists, and techniques of genetic manipulation.
激肽释放酶-激肽原-激肽系统如今备受广泛关注。长期以来,人们对其多样的药理特性和生化特征有所认识,如今对其细胞受体信号转导机制以及生理和病理作用的现代定义进一步丰富了这方面的认识。激肽承担着重要的稳态维持功能,包括在骨骼肌和心肌能量代谢的自分泌和旁分泌信号传导中发挥作用,如今借助更好的激肽释放酶抑制剂、特异性激肽受体拮抗剂以及基因操作技术,这一功能正接受确切的实验评估。